Nitroglycerin: Rapid Relief for Angina Pectoris
| Product dosage: 2.5mg | |||
|---|---|---|---|
| Package (num) | Per cap | Price | Buy |
| 30 | $1.98 | $59.34 (0%) | 🛒 Add to cart |
| 60 | $1.59 | $118.68 $95.46 (20%) | 🛒 Add to cart |
| 90 | $1.45 | $178.02 $130.72 (27%) | 🛒 Add to cart |
| 120 | $1.39 | $237.36 $166.84 (30%) | 🛒 Add to cart |
| 180 | $1.32 | $356.04 $238.22 (33%) | 🛒 Add to cart |
| 270 | $1.28 | $534.06 $345.72 (35%) | 🛒 Add to cart |
| 360 | $1.26
Best per cap | $712.08 $452.36 (36%) | 🛒 Add to cart |
Nitroglycerin is a cornerstone medication in the management of angina pectoris, a condition characterized by chest pain due to myocardial ischemia. As an organic nitrate vasodilator, its primary mechanism of action involves the relaxation of vascular smooth muscle, leading to a reduction in cardiac preload and afterload. This decreases myocardial oxygen demand while simultaneously improving coronary blood flow to ischemic regions of the heart. Available in multiple formulations—sublingual tablets, sprays, ointments, transdermal patches, and intravenous solutions—nitroglycerin offers versatile and rapid therapeutic intervention for both the prevention and acute treatment of angina attacks. Its efficacy, rapid onset of action, and well-documented pharmacokinetic profile have established it as a first-line agent in cardiovascular pharmacotherapy for over a century.
Features
- Active pharmaceutical ingredient: Glyceryl trinitrate.
- Available formulations: Sublingual tablets (0.3 mg, 0.4 mg, 0.6 mg), lingual aerosol spray (0.4 mg per metered dose), topical ointment (2%), transdermal patches (0.1 mg/hr to 0.8 mg/hr), and extended-release capsules.
- Rapid onset of action: Therapeutic effects are typically observed within 1 to 3 minutes for sublingual and spray formulations.
- Duration of effect: Varies by formulation; sublingual/lingual effects last 30-60 minutes, while transdermal patches provide sustained release over 24 hours.
- Pharmacologic class: Organic nitrate vasodilator.
- Metabolism: Extensive first-pass metabolism in the liver, necessitating routes that bypass hepatic circulation (e.g., sublingual, transdermal) for systemic effect.
Benefits
- Provides rapid relief from the acute pain and discomfort of an angina attack.
- Reduces myocardial oxygen demand by dilating veins and arteries, decreasing cardiac preload and afterload.
- Improves coronary blood flow by dilating epicardial coronary arteries and collateral vessels.
- Can be used prophylactically to prevent angina episodes triggered by predictable exertion or stress.
- Offers flexible administration routes to suit individual patient needs and lifestyles.
- Has a long-established safety and efficacy profile backed by extensive clinical use and research.
Common use
Nitroglycerin is primarily indicated for the treatment and prophylaxis of angina pectoris caused by coronary artery disease. Its use is central to the management of both stable exertional angina and unstable angina. In a clinical setting, intravenous nitroglycerin is a critical agent for the management of acute coronary syndromes, congestive heart failure, and perioperative hypertension, especially during cardiac surgery. It is used to control blood pressure in specific scenarios and to induce controlled hypotension during surgical procedures. The choice of formulation is dictated by the clinical context: sublingual tablets or spray for immediate relief of an acute attack, and longer-acting forms like patches or ointment for chronic prophylaxis.
Dosage and direction
Dosing is highly formulation-dependent and must be individualized under medical supervision.
- Sublingual Tablets: At the first sign of an angina attack, place one tablet under the tongue or in the buccal pouch and allow it to dissolve completely. Do not swallow. Dose is typically 0.3 mg to 0.6 mg. If pain persists, a second dose may be taken every 5 minutes for a maximum of 3 doses within a 15-minute period.
- Lingual Spray: Spray one or two metered doses (0.4 mg each) onto or under the tongue. Do not inhale. Do not rinse mouth for 5-10 minutes after administration. The same 15-minute, 3-dose limit applies for acute attacks.
- Ointment: Apply a measured amount (typically starting at 1/2 inch) to a clean, hairless area of skin using the supplied applicator paper. Do not rub in. Sites should be rotated to avoid skin irritation. Usually applied every 3-8 hours with a daily nitrate-free interval.
- Transdermal Patch: Apply one patch to a clean, dry, hairless area of skin on the upper body or arm. Do not apply to distal parts of the extremities. Press firmly in place. Patches are typically worn for 12-14 hours and then removed to provide a 10-12 hour nitrate-free interval to prevent tolerance.
- IV Infusion: Administered in a controlled hospital setting. Initial dosing often starts at 5 mcg/min and is titrated upward by 5 mcg/min every 3-5 minutes based on hemodynamic response and clinical effect.
A daily nitrate-free period of 10-12 hours is essential for all chronic, around-the-clock dosing regimens (ointment, patches) to maintain therapeutic efficacy and prevent tolerance.
Precautions
- Tolerance: Continuous exposure to nitrates leads to tolerance, diminishing their antianginal and hemodynamic effects. A planned daily nitrate-low interval is mandatory for patients on long-acting formulations.
- Hypotension: Nitroglycerin can cause severe hypotension, especially in volume-depleted patients or those already on other antihypertensive agents. This may manifest as dizziness, lightheadedness, or syncope, particularly upon standing (orthostatic hypotension).
- Headache: A common side effect caused by cerebral vasodilation. These often diminish in frequency and severity with continued therapy. Use of analgesics like acetaminophen may be appropriate.
- Rebound Ischemia: Abrupt discontinuation of chronic nitrate therapy, especially without a weaning period, can potentially precipitate rebound angina or ischemia.
- Hypertrophic Cardiomyopathy (HOCM): Use with extreme caution, as nitrate-induced vasodilation may exacerbate left ventricular outflow tract obstruction.
- Storage: Protect tablets from light, moisture, and heat. Keep in the original glass container. Do not transfer to plastic pill boxes or cotton-stoppered containers, as the drug is volatile and will be lost to adsorption and evaporation.
Contraindications
- Known hypersensitivity to nitroglycerin, other nitrates, or nitrites.
- Concurrent use with phosphodiesterase type 5 (PDE5) inhibitors (e.g., sildenafil, tadalafil, vardenafil) or soluble guanylate cyclase stimulators (e.g., riociguat). This combination can cause profound, life-threatening hypotension.
- Severe anemia.
- Increased intracranial pressure (e.g., after head trauma, cerebral hemorrhage).
- Circulatory failure and shock states, including cardiogenic shock and marked hypotension (systolic BP < 90 mmHg).
- Constrictive pericarditis and cardiac tamponade.
- Nitrate therapy is contraindicated in patients with known severe aortic or mitral stenosis.
Possible side effect
The most common side effects are directly related to its vasodilatory properties.
- Headache (often pulsating and severe initially).
- Dizziness, lightheadedness, and orthostatic hypotension.
- Reflex tachycardia.
- Flushing of the face and neck.
- Nausea and vomiting.
- Weakness.
- Less common but serious: Syncope, marked hypotension, paradoxical bradycardia, and exacerbation of angina symptoms. Methemoglobinemia is a rare but serious adverse effect, especially with high doses of IV administration.
Drug interaction
- Phosphodiesterase-5 Inhibitors (e.g., Sildenafil, Tadalafil): Absolute Contraindication. Concomitant use can lead to severe, potentially fatal hypotension.
- Antihypertensive Agents: Additive hypotensive effects with beta-blockers, calcium channel blockers, ACE inhibitors, ARBs, diuretics, and other vasodilators.
- Alcohol: Potentiates the vasodilatory and hypotensive effects of nitroglycerin.
- Dihydroergotamine: Nitrates may increase the bioavailability of dihydroergotamine and exacerbate its vasoconstrictive potential.
- Heparin: IV nitroglycerin has been reported to partially antagonize the anticoagulant effect of heparin, requiring more frequent monitoring of activated partial thromboplastin time (aPTT).
Missed dose
For scheduled, long-acting formulations (patches, ointment): If a dose is missed, apply it as soon as remembered. However, if it is almost time for the next scheduled dose, skip the missed dose and resume the usual dosing schedule. Do not double the dose. For as-needed sublingual formulations: This medication is not on a scheduled dosing regimen. It is taken only at the onset of angina symptoms. There is no concept of a “missed dose.”
Overdose
Nitroglycerin overdose is characterized by severe, life-threatening hypotension, throbbing headache, vertigo, palpitations, visual disturbances, flushing, perspiration, nausea and vomiting, syncope, methemoglobinemia (evidenced by cyanosis, chocolate-brown blood, hypoxia unresponsive to oxygen), and even death. Treatment: Primary treatment is to remove the source (e.g., remove transdermal patch). Place patient in a supine position with legs elevated to maximize venous return. Administer IV fluids for volume expansion. In severe cases, alpha-adrenergic agonists (e.g., phenylephrine) may be required to counteract vasodilation. For methemoglobinemia exceeding 30%, methylene blue (1-2 mg/kg IV over 5 minutes) is the specific antidote.
Storage
- Sublingual Tablets: Store in the original amber glass container with the cap tightly closed. Protect from light, moisture, and heat. Do not store in bathroom cabinets. Do not carry loosely in a pocket, as body heat degrades the drug.
- Lingual Spray: Store at room temperature. Do not puncture or burn container.
- Ointment & Patches: Store at room temperature. Keep ointment tube tightly closed.
- General: Keep all medications out of the reach of children and pets. Unused or expired medication should be disposed of properly via a drug take-back program.
Disclaimer
This information is for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The author and publisher are not responsible for any specific health or allergy needs that may require medical supervision or for any adverse effects resulting from the use of information contained herein.
Reviews
- “As a cardiologist with over 30 years of practice, nitroglycerin remains an indispensable tool. Its rapid action in aborting an acute angina attack is unmatched. The key is proper patient education on administration and the critical nature of the nitrate-free interval to prevent tolerance.” – Dr. A. Reynolds, MD, FACC
- “Living with stable angina for a decade, my nitroglycerin spray is my security blanket. It provides relief within minutes, allowing me to manage my activities with greater confidence. The headaches were intense at first but have subsided significantly.” – Verified Patient
- “From a clinical pharmacy perspective, the various formulations of nitroglycerin allow for highly individualized therapy. However, it demands vigilant patient counseling on storage, administration technique, and the critical contraindication with ED medications to ensure both efficacy and safety.” – Clinical Pharmacist, Major Hospital System
- “The development of tolerance is a significant pharmacological limitation of chronic nitrate therapy that all prescribers must be acutely aware of. The mandatory drug-free window is not a suggestion; it is a requirement for continued effectiveness.” – Cardiovascular Clinical Researcher